Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal

Detalhes bibliográficos
Autor(a) principal: MARIN, Melani Sá
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Digital Unicesumar
Texto Completo: http://rdu.unicesumar.edu.br/handle/123456789/7427
Resumo: With spinal muscular atrophy (SMA) is a specific type of neuromuscular disease, caused by degeneration of motor neurons, resulting in atrophies and progressive muscle weakness. There are several subtypes of the disease, classified based on the age of onset of symptoms. The objective of this research is to verify the level of perception of the families of patients with SMA regarding the effectiveness of using the Spinraza medication associated with physical therapy. Therefore, 114 families of 5 individuals with the disease, who have a closed diagnosis, were selected, and answered a questionnaire prepared by the researchers, applied via social networks. Subsequently, an analysis of the results was carried out and the following data were obtained: Of the types of SMA, type I, is the most frequent and is considered the most serious of all. The medicine Spinraza is an alternative so that the disease does not progress and works by improving muscle strength. A little more than half of the interviewees use the drug, which is obtained, most of the times, by judicial means. Physiotherapy works by preventing disease worsening, and can provide better survival, making it as functional as possible, through exercise-based treatment protocols. Of the 114 respondents, only one does not undergo physical therapy, which demonstrates the significant importance of physical therapy in this context. It is possible to say that the use of the medicine Spinraza brings benefits by itself, and when associated with physiotherapy is more effective, both act to prevent the disease from progressing, providing a better quality of life, although none of them bring a cure.
id UNICESU -1_e356ef9b22076c7e0e0e1ddf089a1616
oai_identifier_str oai:rdu.unicesumar.edu.br:123456789/7427
network_acronym_str UNICESU -1
network_name_str Repositório Digital Unicesumar
repository_id_str
spelling Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhalAmiotonia CongênitaExercício TerapêuticoGenes ModificadoresCNPQ::CIENCIAS DA SAUDEWith spinal muscular atrophy (SMA) is a specific type of neuromuscular disease, caused by degeneration of motor neurons, resulting in atrophies and progressive muscle weakness. There are several subtypes of the disease, classified based on the age of onset of symptoms. The objective of this research is to verify the level of perception of the families of patients with SMA regarding the effectiveness of using the Spinraza medication associated with physical therapy. Therefore, 114 families of 5 individuals with the disease, who have a closed diagnosis, were selected, and answered a questionnaire prepared by the researchers, applied via social networks. Subsequently, an analysis of the results was carried out and the following data were obtained: Of the types of SMA, type I, is the most frequent and is considered the most serious of all. The medicine Spinraza is an alternative so that the disease does not progress and works by improving muscle strength. A little more than half of the interviewees use the drug, which is obtained, most of the times, by judicial means. Physiotherapy works by preventing disease worsening, and can provide better survival, making it as functional as possible, through exercise-based treatment protocols. Of the 114 respondents, only one does not undergo physical therapy, which demonstrates the significant importance of physical therapy in this context. It is possible to say that the use of the medicine Spinraza brings benefits by itself, and when associated with physiotherapy is more effective, both act to prevent the disease from progressing, providing a better quality of life, although none of them bring a cure.A atrofia muscular espinhal (AME) é um tipo de doença neuromuscular específica, causada pela degeneração dos motoneurônios, resultando em atrofias e fraqueza muscular progressiva. Existem vários subtipos da doença, classificada com base na idade de início dos sintomas. O objetivo desta pesquisa foi verificar o nível de percepção das famílias de pacientes com AME sobre a eficácia do uso da medicação Spinraza associada à fisioterapia. Para tanto, foram selecionadas 114 famílias de indivíduos com a doença, que têm diagnóstico fechado, as quais responderam a um questionário elaborado pelas pesquisadoras, o qual foi aplicado via redes sociais. Posteriormente, foi realizada uma análise dos resultados e obteve-se os seguintes dados: dos tipos de AME, a do tipo I é a mais frequente, sendo esta considerada a mais grave entre todas. O medicamento Spinraza é uma alternativa para que a doença não progrida e atue melhorando a força muscular. Pouco mais da metade dos entrevistados fazem uso do fármaco, o qual é obtido, na maioria das vezes, pela via judicial. A fisioterapia atua impedindo agravos da doença, podendo proporcionar uma melhor sobrevida, tornando-o mais funcional possível, por meio de protocolos de tratamentos à base de exercícios. Dos 114 entrevistados, apenas um não faz acompanhamento fisioterapêutico, o que demonstra a significativa importância da fisioterapia nesse contexto. É possível dizer que o uso do medicamento Spinraza traz benefícios por si só e, quando associado à fisioterapia, possui maior eficácia, sendo que ambos atuam para que a doença não progrida, proporcionando melhor qualidade de vida, embora nenhum deles traga a cura.UNIVERSIDADE CESUMARBrasilUNICESUMARCASTRO, Rafaelly Filomena Souza deSÁ, Fabiana Nonino dePALÁCIO, Siméia GasparBELOTO, Amanda BespalhokMARIN, Melani Sá2021-02-12T20:12:10Z2021-02-122021-02-12T20:12:10Z2021-02-12info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfMARIN, Melani Sá. Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal. 25f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.Presencialhttp://rdu.unicesumar.edu.br/handle/123456789/7427porinfo:eu-repo/semantics/openAccessreponame:Repositório Digital Unicesumarinstname:Centro Universitário de Maringá (UNICESUMAR)instacron:UniCesumar2021-02-13T06:02:08ZRepositório InstitucionalPRI
dc.title.none.fl_str_mv Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
title Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
spellingShingle Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
MARIN, Melani Sá
Amiotonia Congênita
Exercício Terapêutico
Genes Modificadores
CNPQ::CIENCIAS DA SAUDE
title_short Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
title_full Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
title_fullStr Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
title_full_unstemmed Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
title_sort Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal
author MARIN, Melani Sá
author_facet MARIN, Melani Sá
author_role author
dc.contributor.none.fl_str_mv CASTRO, Rafaelly Filomena Souza de
SÁ, Fabiana Nonino de
PALÁCIO, Siméia Gaspar
BELOTO, Amanda Bespalhok
dc.contributor.author.fl_str_mv MARIN, Melani Sá
dc.subject.por.fl_str_mv Amiotonia Congênita
Exercício Terapêutico
Genes Modificadores
CNPQ::CIENCIAS DA SAUDE
topic Amiotonia Congênita
Exercício Terapêutico
Genes Modificadores
CNPQ::CIENCIAS DA SAUDE
description With spinal muscular atrophy (SMA) is a specific type of neuromuscular disease, caused by degeneration of motor neurons, resulting in atrophies and progressive muscle weakness. There are several subtypes of the disease, classified based on the age of onset of symptoms. The objective of this research is to verify the level of perception of the families of patients with SMA regarding the effectiveness of using the Spinraza medication associated with physical therapy. Therefore, 114 families of 5 individuals with the disease, who have a closed diagnosis, were selected, and answered a questionnaire prepared by the researchers, applied via social networks. Subsequently, an analysis of the results was carried out and the following data were obtained: Of the types of SMA, type I, is the most frequent and is considered the most serious of all. The medicine Spinraza is an alternative so that the disease does not progress and works by improving muscle strength. A little more than half of the interviewees use the drug, which is obtained, most of the times, by judicial means. Physiotherapy works by preventing disease worsening, and can provide better survival, making it as functional as possible, through exercise-based treatment protocols. Of the 114 respondents, only one does not undergo physical therapy, which demonstrates the significant importance of physical therapy in this context. It is possible to say that the use of the medicine Spinraza brings benefits by itself, and when associated with physiotherapy is more effective, both act to prevent the disease from progressing, providing a better quality of life, although none of them bring a cure.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-12T20:12:10Z
2021-02-12
2021-02-12T20:12:10Z
2021-02-12
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv MARIN, Melani Sá. Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal. 25f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.
Presencial
http://rdu.unicesumar.edu.br/handle/123456789/7427
identifier_str_mv MARIN, Melani Sá. Percepção do uso de Spinraza associado à fisioterapia em indivíduos com atrofia muscular espinhal. 25f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.
Presencial
url http://rdu.unicesumar.edu.br/handle/123456789/7427
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv UNIVERSIDADE CESUMAR
Brasil
UNICESUMAR
publisher.none.fl_str_mv UNIVERSIDADE CESUMAR
Brasil
UNICESUMAR
dc.source.none.fl_str_mv reponame:Repositório Digital Unicesumar
instname:Centro Universitário de Maringá (UNICESUMAR)
instacron:UniCesumar
instname_str Centro Universitário de Maringá (UNICESUMAR)
instacron_str UniCesumar
institution UniCesumar
reponame_str Repositório Digital Unicesumar
collection Repositório Digital Unicesumar
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1747771961633669120